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Phospholipase 4, a ubiquitous lipolytic enzyme that actively catalyzes hydrolysis of phospholipids, has been studied 
as a model for enzyme-substrate r actions, as a membrane structural probe, and as a model for lipid-protein interactions. 
Its mechanism of action remains largely controversial. We report here for the first time direct microscopic observation 
of the lipolytic action of fluorescently marked phospholipase 4 (No& naju naja) against phosphatidylcholine monolayers 
in the lipid phase transition region. Under these conditions, phospholipase 4 is shown to target and hydrolyze solid- 
phase lipid domains of L-a-dipalmitoylphosphatidylcholine. In addition, after a critical extent of monolayer hydrolysis, 
the enzyme itself aggregates into regular, visible proteinaceous domains within the lipid monolayer. Solid-phase lipid 
hydrolysis indicates a preferential hydrolytic environment for phospholipase 4 while enzyme domain formation points 
to a possible allosteric inhibition mechanism by hydrolysis products. 
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1. INTRODUCTION 
Phospholipase A2 (PLA2, EC 3.1.1.4) con- 
stitutes a family of widely studied, ubiquitous, 
small, water-soluble lipolytic enzymes [ 11. PLAz is 
responsible for catalyzing hydrolysis of the 2-acyl 
ester bond of 3-sn-glycerophospholipids to yield 
the acyl fatty acid and corresponding lysolipid. 
The remarkable activation of this enzyme in 
response to organized interfacial phospholipid 
substrates as opposed to dispersed lipid monomers 
[2,3] has made it an ideal investigative tool for pro- 
bing membrane structure [4,5] as well as model en- 
zymatic behavior. However, despite several known 
high-resolution crystal structures of several of 
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these enzymes [6], an array of other structural 
data, and countless kinetic studies of enzymatic 
hydrolysis [ 11, the mechanism of action of PLA2 
remains speculative. To elucidate, in physico- 
chemical terms, the many biochemical processes 
mediated by this enzyme as well as its catalytic ac- 
tion at membrane surfaces, an understanding of its 
interaction with simplified interfaces in phospho- 
lipid model membranes must first be achieved. The 
drastic enhancement of PLA2 hydrolytic activity in 
the lipid phase transition region [7,8] as well as a 
higher hydrolytic activity against gel-phase lipids 
as opposed to liquid-crystalline phases [9,10] are 
important examples of how critical the physical 
state of the lipid substrate is to enzymatic action 
[11,12]. 
Because the influence of the physical state of the 
lipid monolayer on PLAz hydrolytic behavior has, 
until now, only been indirectly inferred, in the pre- 
sent study, the monolayer physical state and its 
relation to subsequent PLA2 hydrolysis of the 
model membrane was directly observed by 
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fluorescence microscopy of monolayers. Fluores- 
cence microscopy has already proven to be a sen- 
sitive optical tool to observe directly and to analyze 
monolayer physical behavior at gas/water inter- 
faces [ 13- 171, particularly in distinguishing forma- 
tion of various solid-phase lipid domains from 
fluid lipid phases in the monolayer phase transition 
region [16,17]. By extending this strategy of 
monolayer physical state visualization with the ad- 
dition of PLA;! into the subphase, we can record 
the interaction between enzyme and monolayer 
substrate optically under various conditions. Real- 
time observations demonstrate the elegance of the 
method to show that PLA2 hydrolysis is directed 
regularly against solid analogue lipid domains in 
the monolayer phase transition region. Correspon- 
ding enzyme aggregation and visible, regular en- 
zyme domain formation implicate hydrolytic end 
products in altering the physical nature of the en- 
zyme and monolayer to inhibit enzyme action. 
2. MATERIALS AND METHODS 
2.1. Materials 
Phospholipase Az (N. naja naja), L-Lu-dipalmitoylphospha- 
tidylcholine and D-rY-dipalmitoylphosphatidylcholine were pur- 
chased from Sigma. Dienoylphosphatidylcholine containing 
C-18 alkyl chains, each with butadiene groups conjugated to the 
glycerol backbone ester linkage in the acyl 1 and 2 positions, 
was synthesized by extending the methods of Pate1 et al. [18]. 
Phospholipids were of greater than 99% purity and showed 
single spots by thin-layer chromatography (TLC) analysis 
(chloroform/methanol/water, 65 : 25 : 4 as eluant solvent). 
Fluorescein isothiocyanate was purchased from Aldrich and 
used as supplied. A fluorescent lipid probe containing sulfo- 
rhodamine in its head group was synthesized using purified 
dioctadecylamine and sulforhodamine isothiocyanate, and 
shown to be pure by TLC. This lipid was shown to partition 
preferentially into the fluid phase of monolayers. 
2.2. Labeling of phospholipase AZ 
PLAz was dissolved from the supplier’s bottle in buffer and 
labeled [19], providing fluorescein labels on 2 of the estimated 
6 lysine residues [20] on each PLAz molecule. The resulting en- 
zyme was indistinguishable from the unlabeled form in its abili- 
ty to hydrolyze DMPC monolayers. However, labeling was 
shown previously by a more sensitive method to reduce 
hydrolytic activity slightly by binding to nonessential lysine 
amine residues on N. naja naja PLA;? [21]. Labeled PLAz was 
separated from unreacted label and buffer salts on Pharmacia 
PD-10 chromatography columns (Sephadex G-25M) 
equilibrated with pure water, and lyophilized under protection 
from light and heat. Product yields were always over 90% and 
were stored in amber glass vials at -22°C. Enzyme solutions 
for interaction with monolayer experiments were made by 
dissolving 0.36 mg labeled PLAz in 26 ml buffer to make a 
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0.014 mg/ml solution. Aliquots of 2.1 ml were frozen in 
polypropylene vials at - 22°C until use. For each experiment, 
0.5 ml thawed PLAz buffer solution was removed from a vial 
with a glass syringe for injection under the monolayer. 
2.3. Fluorescence microscopy of monolayers 
Water for buffer subphases was distilled three times and 
purified through a Millipore filtration apparatus (18 MQ 
resistivity). Tris buffer (10 mM Tris, 150 mM NaCl, 5 mM 
CaClz, pH 8.9, chloroform washed) was prepared by dissolu- 
tion of the various salts in IO-times concentration in acid- 
cleaned glass flasks. Buffer for each experiment was made by 
diluting the concentrated, washed stock 1: 9 with pure water. 
Monolayers were spread over buffer (30°C) from lipid solutions 
in chloroform containing 0.25-1.0 mol% of the fluorescent 
sulforhodamine lipid probe, a probe concentration dilute 
enough so that no changes in isotherm behavior of the main 
lipid component could be detected. Before spreading, the buffer 
surface was cleaned by suction. After spreading, the monolayer 
was immediately compressed by a computer-controlled barrier 
at a rate of 2.5 A2/molecule per min. At a surface pressure ap- 
prox. 3-5 dyn/cm below the start of the phase transition of 
each lipid under the respective conditions, the barrier was stop- 
ped and the enzyme solution (0.5 ml) was injected into the mask 
from a syringe immersed from behind the barrier (fig.la). After 
injection the barrier was restarted and the monolayer compress- 
ed until domains of dark solid-phase lipids in a bright, fluid 
lipid matrix filled the majority of the microscope field. Another 
strategy giving similar results involved injection of enzyme 
under a DPPC monolayer in the lipid phase transition region 
after solid lipid domains had formed. At this point, the field 
was observed alternately through two interchangeable fluores- 
cent filters, corresponding respectively to the monolayer 
(sulforhodamine) marker and the PLAz (fluorescein) marker. 
To eliminate surface flow in the plane of the monolayer, a cir- 
cular mask (fig.lb) was constructed from Teflon (diameter 
20 mm) and inserted into the subphase below the microscope 
objective. The size and design were chosen to eliminate meniscal 
effects on the focal plane of the microscope and to make local 
observations independent of trough geometry. In addition, the 
mask contained an inverted V-shaped slot that faced toward the 
movable barrier of the trough to maintain exchange of localized 
subphase and monolayer components with the external trough 
at all times. With this arrangement, flow problems, which have 
been shown to influence strongly film morphology [22], could 
virtually be eliminated. Flow, over the time scale of observation 
of the enzyme, is also minimized so that specific areas could be 
monitored over hour-long experimental time scales. Video 
recording of the monolayer within the mask with each filter 
through an SIT TV camera was initiated at various time points 
of film hydrolysis. Photographs shown are taken directly from 
the video screen. Specific details regarding the epifluorescent 
microscope and associated Langmuir film balance equipment 
have been recently published elsewhere [16]. 
3. RESULTS AND DISCUSSION 
The sulforhodamine-containing L-wDPPC 
monolayer in the phase transition region was 
displayed by the imaging system as dark solid- 
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Fig.1. Experimental design. Phospholipid monolayers 
containing a small amount of fluorescent sulforhodamine lipid 
probe were compressed over a buffer subphase to the phase 
transition region. Fluorescein-marked PLA was then 
introduced into the subphase under the lipid monolayer (a) 
directly into a mask, (b) placed in the subphase. 
phase L-WDPPC domains in a field of bright mix- 
ture of fluid L-cr-DPPC and sulforhodamine lipid 
(see fig.2A). Pressure-area isotherms and DPPC 
domain morphology in phase transitions were 
similar, if not identical, in form and time- 
dependent annealing behavior to those reported by 
Albrecht et al. [23] and McConnell et al. [24], 
respectively. No signal (i.e. completely dark field) 
was seen upon inverting the optical filter to view 
fluorescein emission. Immediately upon injection 
of fluorescein-marked enzyme into the subphase, 
however, a diffuse, homogeneous fluorescent 
signal could be seen through the fluorescein filter 
(fig.3A). No changes in the sulforhodamine- 
labeled L-WDPPC layer could be detected at this 
point. After 10 min, this enzyme fluorescein signal 
changes little (fig.3B) while observation of the L- 
au;DPPC layer through the sulforhodamine filter 
(fig.ZB) shows the first evidence of L-(u-DPPC 
solid domain hydrolysis, displayed as small, frayed 
indentations in the domain sides, frequently 
located at L-c~-DPPC domain morphological 
discontinuities. This evidence indicates that active 
enzyme attaches, often at only one point, to the 
edge of each L-IY-DPPC domain throughout the 
layer, even though no change in the 
PLAz-fluorescein signal is yet seen. That 
hydrolysis starts exclusively here also indicates that 
this point on the L-a-DPPC domain has a unique 
lipid environment. In addition, that the enzyme 
molecules bind to the edges of the domains in- 
dicates a preferable binding environment between 
liquid and solid regions. This visual evidence, 
shown here for the first time, is strongly supported 
by numerous accounts from other groups of 
enhancement of PLAz lipolytic and binding activi- 
ty in lipid substrate phase transition regions in 
vesicles [7,10,25], and accompanying enzyme ag- 
gregation in its activated state [21,26,27]. These 
reports of activity enhancement in vesicle phase 
transition regions induced by temperature cycling 
are more specifically and directly observed here, 
using more exact isothermal, pressure-induced 
phase transition states with defined lipid domains 
instead. Furthermore, the hypothesis that mem- 
brane defects caused by the phase transition pro- 
Fig.2. Real-time epifluorescent observation of L-a-DPPC monolayer solid domain hydrolysis by PLAz (sulforhodamine filter), 
constant surface pressure = 22 mN/m, buffer subphase; temperature 30°C. (A) Time = 0 (immediately after PLAZ-fluorescein 
injection in subphase, (B) 10, (C) 15, (D) 20, (E) 25, (F) 30, (G) 35, (H) 40, (I) 45, (J) 50, (K) 60, (L) 75 min. Scale: white bar in A 
= 20pm. 
Fig.3. Formation of PLAz domains in L-wDPPC monolayer during phospholipid hydrolysis as observed through epifluorescence 
microscope (fluorescein filter, corresponding photographs with same scale as time points in fig.2), constant surface pressure = 
22 mN/m, buffer subphase, temperature, 30°C. (A) Time = 0 (immediately after PLAx-FITC injection in subphase), (B) 10, (C) 15, 
(D) 20, (E) 25, (F) 30, (G) 35, (H) 40, (I) 45, (J) 50, (K) 60, (L) 75 min. 
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Fig.2 (contd). Fig.3 (contd). 
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Fig.2 (contd). Fig.3 (contd). 
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Fig.2 (c&d). Fig.3 (contd). 
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cess [28-301 account for the increased binding 
affinity and hydrolytic activity of PLA2 support 
our observations of preferential PLAz binding at 
the solid-liquid L_(y-DPPC interfaces. 
By constantly inverting filters back and forth 
over time, we were able to follow the simultaneous 
destruction of L-Q-DPPC solid domains (fig.aB-I) 
together with the unique growth of PLA2 domains 
(fig.3D-L) in identical regions. Each identity 
could not be mistaken because, as seen by compar- 
ing figs 2 and 3, specific signals from each filter are 
inverted as the filters are exchanged, indicating 
positive identification of each domain with either 
L-a-DPPCYsulforhodamine or PLAz-fluorescein, 
respectively, within the monolayer. PLAz do- 
mains, which appear bright through the fluores- 
cein filter, are absolutely dark in the 
sulforhodamine filter, while the L-a-DPPC do- 
mains remain dark in both filters. Control ex- 
periments using solid lipid domains of 
nonhydrolyzable phosphatidylcholines - D-cu- 
DPPC and dienoylphosphatidylcholine [4] - in 
monolayers show absolutely no detectable 
hydrolysis or enzyme domain formation similar to 
that of L-a-DPPC, even after hours of enzyme ex- 
posure. D+DPPC, the stereoisomer of the L- 
form, blocks PLA2 hydrolytic activity [31], but 
shows surface monolayer properties and domain 
characteristics identical to those of the L-form 
[ 151. Moreover, enzyme domain formation was 
not limited exclusively to L-cv-DPPC monolayers. 
PLA2 domains could also be observed in L-c+ 
dimyristoylphosphatidylcholine as well as L-cr- 
phosphatidylethanolamine monolayers in the 
phase transition region (unpublished), indicating 
the validity and applicability of the phenomenon. 
In addition, the necessity for a solid-liquid inter- 
face is indicated by hydrolysis experiments in the 
monolayer gas-liquid expanded analogue phase. 
Under such conditions, no enzyme domains are 
observed, even after 2 h hydrolysis. However, 
when sufficient additional amounts of lipid are 
subsequently spread on this monolayer, prompting 
formation of solid-phase lipid domains, hydrolysis 
is accelerated and enzyme domains appear within 
a few minutes. We believe that interfacial recogni- 
tion, activation and a certain degree of hydrolysis 
are therefore necessary for formation of these 
microscopically observable enzyme domains. 
Over the course of 60 min, the number and size 
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of enzyme domains, as demonstrated by more 
numerous crescent- or kidney-shaped fluorescent 
areas seen through the fluorescein filter (fig.fD-L) 
drastically increase. These enzyme domains retain 
this crescent morphology through the time course 
of their development. Most interestingly, this is 
coupled with corresponding hydrolysis of the L-a- 
DPPC solid domains which degrade from fully in- 
tact, round forms to sequentially and continuously 
hydrolyzed solid-phase, albeit drastically degrad- 
ed, remnants (fig.2B-I). That the lipolytic enzyme 
starts at one point on the L-a-DPPC domain ex- 
terior and hydrolyzes its way through the interior 
in a seemingly regular and directional manner is in- 
triguing and linked possibly to a unique physical 
arrangement of solid-phase L-c~-DPPC molecules. 
One possible mechanism of subsequent enzyme do- 
main formation is that, by hydrolyzing its way 
literally through the cross-section of the L-a- 
DPPC domains, the enzyme creates an increased, 
perturbed interfacial solid L-c~-DPPC border area 
in contact with the fluid phase lipid. This effect, in 
combination with a local concentration of lipid 
sn-2 ester hydrolytic end-products, namely produc- 
tion of the corresponding lysophosphatidylcholine 
and free fatty acid, promotes further potential 
binding and aggregation sites for more enzyme 
in a relatively localized area, thereby serving as a 
site for a self-potentiated PLA2 aggregation 
mechanism. Critical, localized concentration in- 
creases in these end-products together perhaps 
with the unhydrolyzed L-c+DPPC in a ternary 
mixture are speculated to induce localized enzyme 
domain formation and, might we speculate, two- 
dimensional crystallization in specific regions of 
the lipid monolayer. This would suggest an 
allosteric type of enzyme inhibition. In fact, N. na- 
ja naja PLA2 is inhibited by increasing levels of 
free fatty acids [32]. Furthermore, recent evidence 
indicating autocatalyzed self-acylation of snake 
venom PLAz with subsequent enzyme self- 
association [33] could explain larger domain for- 
mation through increased enzyme hydrophobiza- 
tion. Our direct observation of actual enzyme 
domains in regular morphologies trongly supports 
changes in enzyme-substrate binding affinity [32] 
and enzyme structural changes [21] induced 
perhaps by critical changes in the lipid monolayer 
physical state due to the presence of hydrolytic end 
products. This mechanism of aggregation might 
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indeed be a contributing mechanism of allosteric 
enzyme inhibition [32] in the monolayer as well as 
in native cell membranes, and remains an in- 
teresting question that we are pursuing. The time- 
dependent nature of the enzyme domain ap- 
pearance suggests amechanism associated with the 
time- and hydrolysis-dependent inhibition of PLA2 
by end-products together with a substrate- 
dependent (physical state) activation of the 
enzyme. 
In addition to possible monolayer structural 
changes, another consideration regards the local 
changes in monolayer phase transition caused by 
increases in lysolipid and fatty acid content in the 
layer [lo]. Although we cannot yet address 
specifically any quantitative compositional effects 
of these products on the L-a-DPPC phase transi- 
tion, our evidence strongly suggests that L-a- 
DPPC domains remain solid until actively 
hydrolyzed. Slow decompressions of the L-LY- 
DPPC layer, simulating gradual refluidization of 
L-a-DPPC solid domains, show an entirely dif- 
ferent morphological behavior [24]. That the en- 
zyme domain phenomenon was witnessed 
throughout the layer, on nearly all L-(Y-DPPC do- 
mains refutes the possibility that domain forma- 
tion was an artifact. of poorly dispersed, locally 
concentrated enzyme. In addition, the fact that all 
domains sustain independently directed hydrolytic 
vectors, all starting from a point between the 
liquid- and solid-phase L-~Y-DPPC directed 
through the center of each solid domain confirms 
the reality of the phenomenon. 
We have witnessed, for the first time, the unique 
self-association and domain formation of inter- 
facially activated PLAz directly in phospholipid 
monolayers. We propose, in conjunction with 
Hazlett and Dennis [21], that interfacial recogni- 
tion, enzyme aggregation, and hydrolytic activa- 
tion are closely interrelated and interdependent 
requirements for PLA2 behavior., In this regard, 
activation at the membrane interface leads to fur- 
ther enzyme domain growth for small oligomer ag- 
gregates into observable domains, presumably by 
some type of allosteric inhibition mechanism. We 
further conclude that delays in the formation of 
these domains results from time-dependent 
hydrolytic end-product build ups that stimulate en- 
zyme conformational changes with resulting en- 
zyme domain formation in localized areas. 
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